Skip to main content
. 2016 Jan 21;9:520. doi: 10.3389/fnins.2015.00520

Figure 5.

Figure 5

The list of antimuscarinic drugs tested for their AQVN/EIIP. Shaded fields- antimuscarinic drugs within the active domain (Figure 3), white fields-antimuscarinic drugs out of the active domain, bordered fields- antimuscarinic drugs tested for their therapeutical effect on VVS. Probability for the anti VVS activity of muscarinicdrugs, assessed by EIIP/AQVN criterion, is represented with the gray scale (black-the highest probability, white-the lowest probability).